Common Stock, Stock Options and Warrants (Details Textual) |
1 Months Ended | 12 Months Ended | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Aug. 08, 2017
USD ($)
$ / shares
shares
|
Jun. 08, 2017
$ / shares
shares
|
Apr. 07, 2017
$ / shares
shares
|
Jan. 02, 2017
Consultants
$ / shares
shares
|
Sep. 27, 2019 |
Sep. 16, 2019
USD ($)
shares
|
Apr. 03, 2019
USD ($)
$ / shares
shares
|
Feb. 13, 2019
USD ($)
shares
|
Sep. 30, 2018
USD ($)
$ / shares
shares
|
Aug. 13, 2018 |
Apr. 02, 2018
USD ($)
shares
|
Mar. 29, 2018
USD ($)
$ / shares
shares
|
Feb. 07, 2018
USD ($)
Consultants
shares
|
Dec. 19, 2017
USD ($)
$ / shares
shares
|
Nov. 07, 2017
USD ($)
shares
|
Jun. 29, 2017
$ / shares
shares
|
Feb. 28, 2017
USD ($)
$ / shares
shares
|
Feb. 28, 2017
USD ($)
shares
|
Sep. 30, 2019
USD ($)
Consultants
$ / shares
shares
|
Sep. 30, 2018
USD ($)
Consultants
$ / shares
shares
|
Sep. 30, 2017
USD ($)
Consultants
$ / shares
shares
|
Sep. 30, 2016
USD ($)
|
Jun. 07, 2017
USD ($)
shares
|
May 05, 2017
USD ($)
shares
|
Jan. 31, 2017
shares
|
Jun. 01, 2015
$ / shares
|
Apr. 01, 2015
$ / shares
|
Sep. 12, 2014
shares
|
|
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Description of reverse stock split | 1-for-15 | |||||||||||||||||||||||||||
| Common stock, shares issued | shares | 16,198,791 | 28,930,493 | 16,198,791 | 8,345,844 | ||||||||||||||||||||||||
| Common stock value | $ | $ 16,199 | $ 28,930 | $ 16,199 | $ 8,346 | ||||||||||||||||||||||||
| Stock-based compensation | $ | 715,983 | $ 779,701 | $ 986,620 | |||||||||||||||||||||||||
| Proceeds for research and development | $ | 741,843 | |||||||||||||||||||||||||||
| Additional warrant purchase | shares | 12,802 | |||||||||||||||||||||||||||
| Number of additional units sold | shares | 128,017 | |||||||||||||||||||||||||||
| Number of unit offering per share price | $ / shares | $ 6.00 | |||||||||||||||||||||||||||
| Warrant issued to placement agent | $ | $ 58,759 | |||||||||||||||||||||||||||
| Warrants issue | shares | 140,819 | |||||||||||||||||||||||||||
| Fair value of warrants recorded as derivative warrant liability | $ | $ 641,385 | |||||||||||||||||||||||||||
| Stock issued for services and settlements | $ | $ 491,351 | |||||||||||||||||||||||||||
| Common stock, par value | $ / shares | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | ||||||||||||||||||||||||
| Fees and commissions | $ | $ 90,000 | $ 75,000 | $ 50,000 | |||||||||||||||||||||||||
| Stock option purchase grants | shares | 1,090,799 | |||||||||||||||||||||||||||
| Stock option average vest term | 2 years 3 months 19 days | |||||||||||||||||||||||||||
| Prepaid expenses | $ | $ (9,621) | $ (162,514) | (572,098) | |||||||||||||||||||||||||
| Warrants sold and issued to investors | $ | $ 10,000 | 10,000 | ||||||||||||||||||||||||||
| Common stock issued for services fair value | $ | 211,597 | 704,019 | ||||||||||||||||||||||||||
| Other expense | $ | 75,000 | 50,000 | $ 45,000 | |||||||||||||||||||||||||
| Description of warrants | (i) 6,760,615 units, each unit consisting of one share of common stock and one immediately exercisable five-year warrant to purchase one share at $0.77 per share, and (ii) 1,060,615 pre-funded units, each pre-funded unit consisting of one pre-funded warrant to purchase one share and one immediately exercisable five-year warrant to purchase one share at $0.77 per share. The pre-funded warrants included in the pre-funded units are immediately exercisable at a price of $0.0001 per share and do not expire. The offering price was $0.8951 per unit and $0.895 per pre-funded unit. The net proceeds of the offering were $6,290,335. The Company issued the underwriter immediately exercisable five-year warrants to purchase up to 547,486 shares at $1.118875 per share with an estimated fair value of $323,414. The estimated fair value of the 1,060,615 pre-funded warrants was $809,145, and the estimated fair value of the 7,821,230 warrants included in the units and the pre-funded units issued to the investors was $4,845,341. | (i) 5,521,569 units, each unit consisting of one share of common stock and one immediately exercisable five-year warrant to purchase one share at $1.15 per share, and (ii) 2,321,569 pre-funded units, each pre-funded unit consisting of one pre-funded warrant to purchase one share and one immediately exercisable five-year warrant to purchase one share at $1.15 per share. The pre-funded warrants included in the pre-funded units are immediately exercisable at a price of $0.01 per share and do not expire. The offering price was $1.275 per unit and $1.265 per pre-funded unit. The net proceeds of the offering were $8,926,786. The Company issued underwriter warrants to purchase up to 549,020 shares at $1.59375 per share with an estimated fair value of $491,737. The underwriter warrants are exercisable following February 8, 2019 and expire on August 8, 2023. The estimated fair value of the 2,321,569 pre-funded warrants was $2,630,072, and the estimated fair value of the 7,843,138 warrants included in the units and the pre-funded units issued to the investors was $7,311,727. | ||||||||||||||||||||||||||
| Proceeds from common stock warrant exercises | $ | $ 23,216 | $ 1,125,148 | ||||||||||||||||||||||||||
| Weighted average period | 1 year 7 months 28 days | |||||||||||||||||||||||||||
| weighted average remaining life of all of the outstanding warrants | 3 years 7 months 17 days | |||||||||||||||||||||||||||
| Aggregate intrinsic value for the warrants outstanding | $ | $ 805,961 | |||||||||||||||||||||||||||
| Maximum [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Exercise price of warrants | $ / shares | $ 1.27 | |||||||||||||||||||||||||||
| Minimum [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Exercise price of warrants | $ / shares | $ 0.94 | |||||||||||||||||||||||||||
| 2017 Public Offering [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Common stock issued for services | shares | 100,000 | |||||||||||||||||||||||||||
| Common stock issued for services fair value | $ | $ 60,000 | |||||||||||||||||||||||||||
| Underwriter payment, restricted common stock fair value | $ | 257,400 | |||||||||||||||||||||||||||
| Other expense | $ | $ 357,400 | |||||||||||||||||||||||||||
| Registered Direct and Private Placement Offering [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Exercise price of warrants | $ / shares | $ 1.42 | $ 2.86 | ||||||||||||||||||||||||||
| Warrants sold and issued to investors | $ | $ 420,566 | |||||||||||||||||||||||||||
| Warrants issued | shares | 89,625 | |||||||||||||||||||||||||||
| Percentage of offering fee | 7.00% | |||||||||||||||||||||||||||
| Term of warrants | 5 years | |||||||||||||||||||||||||||
| Stock Options [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Common stock outstanding | shares | 1,601,039 | 1,771,039 | 1,601,039 | |||||||||||||||||||||||||
| Weighted-average remaining contractual term, exercisable | 7 years 1 month 9 days | |||||||||||||||||||||||||||
| Stock options to purchase exercised | shares | ||||||||||||||||||||||||||||
| Aggregate intrinsic value for the warrants outstanding | $ | $ 49,465 | |||||||||||||||||||||||||||
| Share-based payment award, description | In September 2018, the Board of Directors granted stock options to purchase a total of 520,000 shares to six employees, 75,000 options to five directors, and 80,000 options to three consultants at $1.62 per share. | |||||||||||||||||||||||||||
| Omnibus Stock Incentive Plan [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Common stock, shares issued | shares | 2,000,000 | |||||||||||||||||||||||||||
| Stock option purchase grants | shares | 1,085,000 | |||||||||||||||||||||||||||
| Financial advisor warrants exercised | shares | 915,000 | |||||||||||||||||||||||||||
| Private Offering [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Settlement expense | $ | $ 161,771 | |||||||||||||||||||||||||||
| Issuance of common stock in private placement, net of costs, shares | shares | 58,191 | |||||||||||||||||||||||||||
| Stock Options [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Stock options to purchase exercised | shares | ||||||||||||||||||||||||||||
| Purchase Options Units [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Other expense | $ | $ 96,930 | $ 96,930 | ||||||||||||||||||||||||||
| Employee [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Stock options to purchase exercised | shares | 165,000 | |||||||||||||||||||||||||||
| Stock option estimated fair value, shares | shares | 0.94 | |||||||||||||||||||||||||||
| Accredited Investors [Member] | Registered Direct and Private Placement Offering [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Number of units sold | shares | 669,504 | 1,280,360 | ||||||||||||||||||||||||||
| Exercise price of warrants | $ / shares | $ 4.6925 | |||||||||||||||||||||||||||
| Warrants sold and issued to investors | $ | $ 5,300,001 | $ 1,998,469 | $ 6,008,089 | |||||||||||||||||||||||||
| Sale of common stock | shares | 669,504 | 1,280,360 | ||||||||||||||||||||||||||
| Investor [Member] | Registered Direct and Private Placement Offering [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Number of units sold | shares | 3,430,421 | 669,504 | ||||||||||||||||||||||||||
| Exercise price of warrants | $ / shares | $ 5.8656 | |||||||||||||||||||||||||||
| Amendements to fair value of warrants | $ | $ 3,430,421 | $ 669,504 | ||||||||||||||||||||||||||
| Warrants sold and issued to investors | $ | $ 2,709,467 | $ 1,679,482 | ||||||||||||||||||||||||||
| Sale of common stock | shares | 3,430,421 | 669,504 | ||||||||||||||||||||||||||
| Description of warrants | The Company sold the investors 640,180 immediately exercisable five and a half year warrants at $4.63 per share. | |||||||||||||||||||||||||||
| Warrants issued | shares | 640,180 | |||||||||||||||||||||||||||
| Estimated fair value of the warrant granted to the placement agent | $ | $ 2,407,276 | |||||||||||||||||||||||||||
| Placement Agent [Member] | Registered Direct and Private Placement Offering [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Number of units sold | shares | 3,430,421 | 669,504 | ||||||||||||||||||||||||||
| Number of units sold for gross proceeds | $ | $ 46,866 | |||||||||||||||||||||||||||
| Sale of stock price | $ / shares | $ 1.545 | $ 2.985 | ||||||||||||||||||||||||||
| Other cash expenses related to placements | $ | $ 85,000 | $ 85,000 | 85,000 | |||||||||||||||||||||||||
| Warrants sold and issued to investors | $ | 169,854 | 110,511 | 5,482,523 | |||||||||||||||||||||||||
| Other expense | $ | $ 10,000 | $ 10,000 | $ 20,000 | |||||||||||||||||||||||||
| Sale of common stock | shares | 3,430,421 | 669,504 | ||||||||||||||||||||||||||
| Description of warrants | The Company paid the placement agent a fee of 7% of the gross proceeds totaling $371,000 and issued the placement agent 240,130 immediately exercisable two-year warrants with an exercise price of $1.93125 per share. | The Company paid the placement agent a fee of 7% of the gross proceeds totaling $139,893 and issued the placement agent 46,866 immediately exercisable five-year warrants at $3.73125 per share. | ||||||||||||||||||||||||||
| Warrants issued | shares | 240,130 | 46,866 | 89,625 | |||||||||||||||||||||||||
| Percentage of offering fee | 7.00% | 7.00% | ||||||||||||||||||||||||||
| Term of warrants | 2 years | 5 years | ||||||||||||||||||||||||||
| Estimated fair value of the warrant granted to the placement agent | $ | $ 316,071 | |||||||||||||||||||||||||||
| Proceeds from common stock warrant exercises | $ | $ 4,834,001 | $ 1,763,576 | ||||||||||||||||||||||||||
| Executive Chairman [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Common stock exercise price per share | $ / shares | $ 10.05 | $ 3.45 | ||||||||||||||||||||||||||
| Stock options to purchase exercised | shares | 8,669 | 25,000 | 520,000 | 225,000 | ||||||||||||||||||||||||
| Stock option purchase grants | shares | 80,000 | 50,000 | ||||||||||||||||||||||||||
| Weighted average grant-date estimated per share | $ / shares | $ 1.75 | |||||||||||||||||||||||||||
| Stock option average vest term | 10 years | 10 years | 10 years | 10 years | ||||||||||||||||||||||||
| Stock option estimated fair value, shares | shares | 8.41 | 1.04 | 1.45 | 2.95 | ||||||||||||||||||||||||
| Number of consultants | Consultants | 4 | 4 | 3 | 2 | ||||||||||||||||||||||||
| Options vest, description | These options vest over terms of 12 to 36 months and have a term of 10 years. | These options vest over terms of 12 to 36 months and have a term of 10 years. | These options vest over terms of 12 to 36 months and have a term of 10 years. | These options vest over terms of 12 to 36 months and have a term of 10 years. | ||||||||||||||||||||||||
| Executive Chairman [Member] | Stock Options [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Common stock exercise price per share | $ / shares | $ 9.00 | $ 9.00 | ||||||||||||||||||||||||||
| Leonard Meron Biosciences [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Common stock, shares issued | shares | 11,400 | |||||||||||||||||||||||||||
| Common stock value | $ | $ 77,748 | |||||||||||||||||||||||||||
| Settlement expense | $ | $ 77,748 | |||||||||||||||||||||||||||
| Financial Consultant [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Stock options to purchase exercised | shares | 70,000 | |||||||||||||||||||||||||||
| Purchase Options Units [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Common stock exercise price per share | $ / shares | $ 9.00 | $ 9.00 | ||||||||||||||||||||||||||
| Warrants outstanding purchase of common stock, shares | shares | 193,860 | 104,138 | ||||||||||||||||||||||||||
| Number of unit purchase | shares | 38,000 | 62,667 | ||||||||||||||||||||||||||
| Number of units purchase, per unit | $ / shares | $ 9.00 | $ 9.00 | ||||||||||||||||||||||||||
| Common Stock [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Common stock, shares issued | shares | 866,667 | |||||||||||||||||||||||||||
| Stock-based compensation | $ | ||||||||||||||||||||||||||||
| Stock issued for services and settlements | $ | $ 128 | |||||||||||||||||||||||||||
| Issuance of common stock in private placement, net of costs, shares | shares | 128,016 | |||||||||||||||||||||||||||
| Stock options to purchase exercised | shares | 4,829 | |||||||||||||||||||||||||||
| Stock option purchase grants | shares | 5,799 | |||||||||||||||||||||||||||
| Number of consultants | Consultants | 2 | |||||||||||||||||||||||||||
| Common stock issued for services | shares | 94,097 | 125,000 | 10,000 | 22,200 | 219,097 | 140,843 | ||||||||||||||||||||||
| Common stock issued for services fair value | $ | $ 94,097 | $ 117,500 | $ 31,000 | $ 88,800 | $ 219 | $ 141 | ||||||||||||||||||||||
| Financial advisor warrants exercised | shares | 4,829 | 4,829 | ||||||||||||||||||||||||||
| Retained Earnings [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Stock-based compensation | $ | ||||||||||||||||||||||||||||
| Stock issued for services and settlements | $ | ||||||||||||||||||||||||||||
| Common stock issued for services fair value | $ | ||||||||||||||||||||||||||||
| Additional Paid-in Capital [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Stock-based compensation | $ | 715,983 | $ 779,701 | 986,620 | |||||||||||||||||||||||||
| Stock issued for services and settlements | $ | 491,223 | |||||||||||||||||||||||||||
| Common stock issued for services fair value | $ | $ 211,378 | 703,878 | ||||||||||||||||||||||||||
| Preferred Stock [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Stock-based compensation | $ | ||||||||||||||||||||||||||||
| Stock issued for services and settlements | $ | ||||||||||||||||||||||||||||
| Stock options to purchase exercised | shares | ||||||||||||||||||||||||||||
| Common stock issued for services | shares | ||||||||||||||||||||||||||||
| Common stock issued for services fair value | $ | ||||||||||||||||||||||||||||
| Warrant [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Exercise of outstanding warrants | $ | $ 25,492,513 | |||||||||||||||||||||||||||
| 2017 Public Offering and Release Agreement [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Number of unit offering per share price | $ / shares | $ 4.125 | |||||||||||||||||||||||||||
| Exercise price of warrants | $ / shares | $ 4.125 | |||||||||||||||||||||||||||
| Share issued | shares | 1,648,484 | |||||||||||||||||||||||||||
| Weighted-average remaining contractual term, exercisable | 5 years | |||||||||||||||||||||||||||
| Warrants to purchase | shares | 1,648,484 | |||||||||||||||||||||||||||
| Warrants to purchase of common stock price per share | $ / shares | $ 0.01 | |||||||||||||||||||||||||||
| 2017 Public Offering [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Issuance of common stock in private placement, net of costs, shares | shares | 58,191 | |||||||||||||||||||||||||||
| Common stock, par value | $ / shares | $ 4.125 | |||||||||||||||||||||||||||
| 2017 Public Offering [Member] | Common Stock [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Stock sold for gross proceeds | $ | $ 6,802,469 | |||||||||||||||||||||||||||
| Unit purchase options, description | The Company granted the underwriters a 45-day option to purchase up to an additional 247,272 shares of common stock and warrants to purchase 247,272 shares of common stock to cover over-allotments, if any. On August 8, 2017, the underwriters partially exercised the over-allotment to purchase an additional 247,272 warrants. The estimated fair value of the 1,895,756 warrants issued to the investors was $4,160,195 and the estimated fair value of the 65,940 warrants issued to the underwriters was $142,419. | |||||||||||||||||||||||||||
| Common stock, par value | $ / shares | $ 4.125 | |||||||||||||||||||||||||||
| Fees and commissions | $ | $ 685,573 | |||||||||||||||||||||||||||
| Weighted-average remaining contractual term, exercisable | 5 years | |||||||||||||||||||||||||||
| Investor Warrants [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Common stock, shares issued | shares | 29,729 | |||||||||||||||||||||||||||
| Warrants issue | shares | 128,017 | 128,017 | ||||||||||||||||||||||||||
| Fair value of common stock | $ | $ 587,592 | 298,774 | ||||||||||||||||||||||||||
| Common stock outstanding | shares | 202,469 | 202,469 | ||||||||||||||||||||||||||
| Stock option estimated fair value | $ | $ 4,160,195 | |||||||||||||||||||||||||||
| Stock option estimated fair value, shares | shares | 1,895,756 | |||||||||||||||||||||||||||
| Offering Warrants [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Warrants outstanding purchase of common stock, shares | shares | 12,802 | |||||||||||||||||||||||||||
| Additional warrant purchase | shares | 12,802 | 12,802 | ||||||||||||||||||||||||||
| Number of units sold | shares | 128,017 | |||||||||||||||||||||||||||
| Number of units sold, per unit | $ / shares | $ 6.00 | |||||||||||||||||||||||||||
| Number of units sold for gross proceeds | $ | $ 768,100 | |||||||||||||||||||||||||||
| Expense allowance, percentage | 3.00% | |||||||||||||||||||||||||||
| Percentage of cash commission on gross proceeds | 10.00% | |||||||||||||||||||||||||||
| Warrants issue | shares | 272,767 | 272,767 | ||||||||||||||||||||||||||
| Exercise price of warrants | $ / shares | $ 4.125 | $ 4.25 | $ 4.25 | |||||||||||||||||||||||||
| Sale of common stock | shares | 128,017 | |||||||||||||||||||||||||||
| Proceeds from common stock warrant exercises | $ | $ 1,125,148 | |||||||||||||||||||||||||||
| Placement Agent Unit Warrants [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Number of units sold | shares | 128,017 | |||||||||||||||||||||||||||
| Expense allowance | $ | $ 99,853 | |||||||||||||||||||||||||||
| Warrant offering description | The Company sold 128,017 units at $6.00 per unit for gross proceeds of $768,100. Each unit consisted of (i) one share of common stock and (ii) a five-year warrant to purchase one share of common stock at an exercise price of $8.25 per share. The placement agent received a 10% cash commission on the gross proceeds, an expense allowance equal to 3% of the proceeds, and warrants to purchase 12,802 shares of common stock at an exercise price of $8.25 per share. The estimated fair value of the 128,017 warrants issued to the investors was $587,592 and the estimated fair value of the 12,802 warrants issued to the placement agent was $58,759. The placement agent commissions and expense allowance was $99,853. Other costs of the placement were $176,896. | |||||||||||||||||||||||||||
| Warrants issue | shares | 12,802 | |||||||||||||||||||||||||||
| Fair value of common stock | $ | $ 587,592 | |||||||||||||||||||||||||||
| Other cost | $ | $ 176,896 | |||||||||||||||||||||||||||
| Sale of common stock | shares | 128,017 | |||||||||||||||||||||||||||
| Underwriters [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Stock option estimated fair value | $ | $ 142,419 | |||||||||||||||||||||||||||
| Stock option estimated fair value, shares | shares | 65,940 | |||||||||||||||||||||||||||
| Offering [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Common stock, shares issued | shares | 6,668 | |||||||||||||||||||||||||||
| Common stock value | $ | $ 45,476 | |||||||||||||||||||||||||||
| Settlement expense | $ | $ 45,476 | |||||||||||||||||||||||||||
| Description of release agreements | In exchange, the Company agreed that (i) in the event that a financing is conducted at a price per share or price per unit lower than $6.00, then the Company will issue additional shares to each investor sufficient to effectively reprice the sale of the 2016 Offering units to the lower price; (ii) in the event that the financing is conducted at a price per share or price per unit less than the $8.25 exercise price of the warrants issued in the 2016 Offering then the exercise price of the warrants shall be reduced to the lower price; and (iii) the Company will give each investor no less than 6 hours of notice before the closing of any subsequent financing, through and including the Company's 2017 registered public offering, and each investor shall have a 6-hour option to purchase up to 20% of the securities sold in such offering. In connection with these agreements the Company reclassified the $641,385 fair value of the 140,819 warrants issued in the 2016 Offering to derivative warrant liability on June 8, 2017. On August 8, 2017, the Company completed its 2017 public offering and issued 58,191 shares of common stock to the investors in the 2016 Offering to reprice the sale of the 2016 Offering units to $4.125 per unit and repriced the 2016 Offering Warrants to an exercise price of $4.125 per share. During the year ended September 30, 2017, the Company recorded a settlement expense of $161,771 in connection with the issuance of the additional 58,191 shares of common stock and reclassified the current fair value of the warrants to additional paid-in capital. | |||||||||||||||||||||||||||
| Warrants outstanding purchase of common stock, shares | shares | 140,819 | |||||||||||||||||||||||||||
| Exercise price of warrants | $ / shares | $ 4.125 | |||||||||||||||||||||||||||
| Offering pre-Funded [Member] | ||||||||||||||||||||||||||||
| Common Stock, Stock Options and Warrants (Textual) | ||||||||||||||||||||||||||||
| Warrants issue | shares | 2,321,569 | |||||||||||||||||||||||||||
| Exercise price of warrants | $ / shares | $ 0.01 | |||||||||||||||||||||||||||
| Proceeds from common stock warrant exercises | $ | $ 23,216 | |||||||||||||||||||||||||||